CONCURRENT RADIOCHEMIOTHERAPHY AND SURGERY IN NSCLC . A PHASE II MULTICENTRIC STUDY
- Conditions
- neoadiuvant treatment for locally advanced nsclcMedDRA version: 9.1Level: LLTClassification code 10041068Term: Small cell lung cancer extensive stage
- Registration Number
- EUCTR2004-005027-18-IT
- Lead Sponsor
- POLICLINICO UNIVERSITARIO AGOSTINO GEMELLI
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Recruiting
- Sex
- All
- Target Recruitment
- Not specified
Inclusion Criteria
Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range
F.1.3 Elderly (>=65 years) yes
F.1.3.1 Number of subjects for this age range
Exclusion Criteria
Not provided
Study & Design
- Study Type
- Interventional clinical trial of medicinal product
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Main Objective: RISPOSTA, TOLLERANZA DISTRETTUALE E SISTEMICA, INDICE DI RESECABILITa' CHIRURGICA, RISPOSTE PATOLOGICHE,VALUTAZIONE COMPLICANZE E RECIDIVE LOCALI O SISTEMICHE EFFETTI COLLATERALI TARDIVI, TEMPO DI PROGRESSIONE <br>;Secondary Objective: SOPRAVVIVENZA <br>;Primary end point(s): CLINICAL RESPONSE, FEASIBILITY,RESECABILITY, PATOLOGICAL DOWN STAGING,SIDE EFFECTS,LOCAL AND DISTANCE RECURRENCES, TIME TO PROGRESSION <br>
- Secondary Outcome Measures
Name Time Method